Interaction of Epac with Non-canonical Cyclic Nucleotides
Files
Publication date
2017
Editors
Seifert, Roland
Advisors
Supervisors
Document Type
Part of book
Metadata
Show full item recordCollections
License
taverne
Abstract
Epac1 and Epac2 are cyclic nucleotide-binding (CNB) domain containing proteins, which were originally identified as cAMP-regulated guanine nucleotide exchange factors (GEFs) for the small G-protein Rap. Therefore, Epac proteins founded next to protein kinase A (PKA) and cyclic nucleotide-regulated ion channels the third group of cAMP-responsive proteins in higher organisms. Epac proteins are involved in the regulation of several physiological processes. In particular Epac1 mediates the regulation of molecular processes underlying cell adhesion and mobility. In the pancreas activation of Epac2 potentiates the release of glucose-induced insulin secretion and received attention as a putative target for antidiabetic treatment. While the regulation of Epac by cAMP has been analysed in structural and biochemical detail, less is known on the interaction of Epac with non-canonical cyclic nucleotides. This chapter will discuss to what extent other cyclic purines than cAMP or cyclic pyrimidine could act as Epac agonists or antagonists. The focus will be on the biophysical analysis of the interaction between Epac and these cyclic nucleotides.
Keywords
Epac, Guanine nucleotide exchange factor, Rap, RapGEF, Small G-protein, Biochemistry, General Pharmacology, Toxicology and Pharmaceutics
Citation
Rehmann, H 2017, Interaction of Epac with Non-canonical Cyclic Nucleotides. in R Seifert (ed.), Non-canonical Cyclic Nucleotides. Handbook of Experimental Pharmacology, vol. 238, Springer International Publishing, pp. 135-147. https://doi.org/10.1007/164_2015_37